Jin Medical International Ltd. (ZJYL)

NASDAQ: ZJYL · Real-Time Price · USD

1.870

+0.060 (3.31%)

At close: Jul 10, 2026, 4:00 PM EDT

1.980

+0.110 (5.88%)

After-hours: Jul 10, 2026, 5:40 PM EDT

Jin Medical International Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Net Income	1.38	3.42	2.88	2.71	2.63
Depreciation & Amortization	0.24	0.24	0.23	0.36	0.35
Other Adjustments	0.18	0.05	0.2	-0.06	-0.1
Change in Receivables	2.27	-3.91	-0.38	0.33	3.08
Changes in Inventories	0.17	0.08	1.56	-0.5	0.46
Changes in Accounts Payable	0.29	-0.5	-0.65	-0.81	-0.37
Changes in Accrued Expenses	0.25	0.1	-0.07	-0.28	0.03
Changes in Income Taxes Payable	-0.79	0.82	0.03	0.16	-0.1
Changes in Unearned Revenue	-0.17	-0.06	0.02	-0.76	0.65
Changes in Other Operating Activities	-0.92	-1.45	-0.72	0.43	-0.79
Operating Cash Flow	2.9	-1.21	3.11	1.58	5.84
Operating Cash Flow Growth	-	-	96.53%	-72.95%	133.44%
Capital Expenditures	-6.63	-0.14	-0.11	-0.04	-0.04
Sale of Property, Plant & Equipment	0	0	0.01	-	-
Purchases of Intangible Assets	-	-0.98	-	-	-
Purchases of Investments	-9.7	-21.05	-12.05	-5.65	-4.96
Proceeds from Sale of Investments	6.04	12.66	4.43	5.2	4.15
Payments for Business Acquisitions	-0.5	-	-	-	-
Other Investing Activities	-	-	-	0.36	-0.22
Investing Cash Flow	-10.79	-9.51	-7.73	-0.12	-1.07
Short-Term Debt Issued	19.02	12.43	5.67	-	0.77
Short-Term Debt Repaid	-11.43	-5.56	-1.42	-	-3.53
Net Short-Term Debt Issued (Repaid)	7.59	6.87	4.25	-	-2.77
Issuance of Common Stock	-	0.31	7.12	-	-
Net Common Stock Issued (Repurchased)	-	0.31	7.12	-	-
Other Financing Activities	-0.24	4.48	-4.47	0.12	-0.1
Financing Cash Flow	7.35	11.65	6.91	0.12	-2.87
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.14	0.27	-0.15	-0.46	0.1
Net Cash Flow	-0.67	1.21	2.14	1.12	2.01
Free Cash Flow	-3.73	-1.35	2.99	1.54	5.8
Free Cash Flow Growth	-	-	94.25%	-73.44%	145.69%
FCF Margin	-18.01%	-5.75%	15.10%	8.03%	27.93%
Free Cash Flow Per Share	-0.48	-0.17	0.41	0.23	0.86
Levered Free Cash Flow	1.22	9.62	7.42	1.26	0.05
Unlevered Free Cash Flow	-6.88	3.38	3.46	0.66	2.59

SEC Filings: 10-K · 10-Q